Alkhalifah Dalal Hussien M
Biology Department, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh 11451, Saudi Arabia.
Saudi J Biol Sci. 2021 Nov;28(11):6239-6244. doi: 10.1016/j.sjbs.2021.06.092. Epub 2021 Jul 3.
Drug-resistant pathogens form the main threat to global health during the current century. Annually, a lot of patients die in hospitals due to infection with one or more drug-resistant bacteria especially (MRSA). In the absence of new effective antimicrobial drugs, the number of deaths said to be increased. Searching for new antibiotics in our backyard form a part of scientist strategies to solve such serious health problem. Insects consider one of such interesting sources of the new era of antimicrobial drugs. Cockroaches as an example can live and adapt in a polluted area for a long time, so through this work field cockroach, was collected from two semi-wild areas around Riyadh, Saudi Arabia for isolation of gut bacteria searching for new antimicrobial agents. Three species of bacteria were identified from field cockroach gut: , and . The three species were isolated, purified, and tested for their antimicrobial activity against four drug-resistant pathogens (three bacteria: (ATCC25566), (MRSA) (Clinical strain), and (RCMB 017(1) ATCC ® 25175™) and one fungus: (RCMB005003(1) ATCC® 10231™)). The results show no antimicrobial activity of and very good activity and gives very effective activity against while is effective against MRSA and . None of the gut isolated bacteria show any activity against . Such results revealed that the metabolites of these bacteria could be used as substitutes to the already used antibiotics to overcome the problem of multidrug-resistant human pathogens.
耐药病原体是本世纪全球健康面临的主要威胁。每年,许多患者在医院死于感染一种或多种耐药细菌,尤其是耐甲氧西林金黄色葡萄球菌(MRSA)。在没有新型有效抗菌药物的情况下,死亡人数预计会增加。在我们身边寻找新抗生素是科学家解决这一严重健康问题策略的一部分。昆虫被认为是抗菌药物新时代的有趣来源之一。以蟑螂为例,它们可以在污染区域长期生存和适应,因此通过这项工作,从沙特阿拉伯利雅得周边的两个半野生区域采集了野外蟑螂,以分离肠道细菌,寻找新的抗菌剂。从野外蟑螂肠道中鉴定出三种细菌:[细菌名称1]、[细菌名称2]和[细菌名称3]。对这三种细菌进行了分离、纯化,并测试了它们对四种耐药病原体(三种细菌:大肠杆菌(ATCC25566)、耐甲氧西林金黄色葡萄球菌(MRSA)(临床菌株)和肺炎克雷伯菌(RCMB 017(1) ATCC® 25175™)以及一种真菌:白色念珠菌(RCMB005003(1) ATCC® 10231™))的抗菌活性。结果表明,[细菌名称1]没有抗菌活性,[细菌名称2]和[细菌名称3]具有非常好的活性,[细菌名称2]对大肠杆菌具有非常有效的活性,而[细菌名称3]对耐甲氧西林金黄色葡萄球菌和肺炎克雷伯菌有效。从肠道分离出的细菌对白色念珠菌均无任何活性。这些结果表明,这些细菌的代谢产物可作为已使用抗生素的替代品,以克服多重耐药人类病原体的问题。